-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Maintains Buy on Tenaya Therapeutics, Lowers Price Target to $3

Benzinga·12/12/2025 16:18:52
Listen to the news
HC Wainwright & Co. analyst Joseph Pantginis maintains Tenaya Therapeutics (NASDAQ:TNYA) with a Buy and lowers the price target from $5 to $3.